194
Views
3
CrossRef citations to date
0
Altmetric
Original

Understanding comorbidity? Australian service-user and provider perspectives on drug treatment and mental-health literacy

&
Pages 518-531 | Published online: 10 Jul 2009

References

  • Bauman AE, Fardy HJ, Harris PG. Getting it right: Why bother with patient-centred care?. Medical Journal of Australia 2003; 179: 253–256
  • Burns JR, Rapee RM. Adolescent mental health literacy: Young people's knowledge of depression and help seeking. Journal of Adolescence 2006; 29: 225–239
  • Callaly T, Trauer T, Munro L, Whelan G. Prevalence of psychiatric disorder in a methadone maintenance population. Australian and New Zealand Journal of Psychiatry 2001; 35: 601–605
  • Carder PC, Vuckovic N, Green CA. Negotiating medications: Patient perceptions of long-term medication use. Journal of Clinical Pharmacy and Therapeutics 2003; 28: 409–417
  • Glaser BG, Strauss AL. The discovery of grounded theory: Strategies for qualitative research. Weidenfeld & Nicolson, London 1967
  • Goldman LS, Nielsen NH, Champion HC. Awareness, diagnosis, and treatment of depression. Journal of General Internal Medicine 1999; 14: 569–580
  • Goldney RD, Fisher LJ, Wilson DH. Mental health literacy: An impediment to the optimum treatment of major depression in the community. Journal of Affective Disorders 2001; 64: 277–284
  • Goldney RD, Fisher LJ, Wilson DH, Cheok F. Mental health literacy of those with major depression and suicidal ideation: An impediment to help seeking. Suicide and Life-Threatening Behavior 2002; 32: 394–403
  • Greig RL, Baker A, Lewin TJ, Webster RA, Carr VJ. Long-term follow-up of people with co-existing psychiatric and substance use disorders: Patterns of use and outcomes. Drug and Alcohol Review 2006; 25: 249–258
  • Hall W. What have population surveys revealed about substance use disorders and their comorbidity with other mental disorders?. Drug and Alcohol Review 1996; 15: 157–170
  • Hall W, Teesson M, Lynskey M, Degenhardt L. The 12-month prevalence of substance use and ICD-10 substance use disorders in Australian adults: Findings from the National Survey of Mental Health and Wellbeing. Addiction 1999; 94: 1541–1550
  • Havard A, Teesson M, Darke S, Ross J. Depression among heroin users: 12-month outcomes from the Australian Treatment Outcome Study (ATOS). Journal of Substance Abuse Treatment 2006; 30: 355–362
  • Hickie IB, Koschera A, Davenport TA, Naismith SL, Scott EM. Comorbidity of common mental disorders and alcohol or other substance misuse in Australian general practice. Medical Journal of Australia 2001; 175: S31–S36
  • Holt M. Agency and dependency within treatment: Drug treatment clients negotiating methadone and antidepressants. Social Science & Medicine 2007; 64: 1937–1947
  • Jorm AF. Mental health literacy: Public knowledge and beliefs about mental disorders. British Journal of Psychiatry 2000; 177: 396–401
  • Jorm AF, Barney LJ, Christensen H, Highet NJ, Kelly CM, Kitchener BA. Research on mental health literacy: What we know and what we still need to know. Australian and New Zealand Journal of Psychiatry 2006; 40: 3–5
  • Jorm AF, Christensen H, Griffiths KM. The impact of Beyondblue: The national depression initiative on the Australian public's recognition of depression and beliefs about treatments. Australian and New Zealand Journal of Psychiatry 2005; 39: 248–254
  • Jorm AF, Korten AE, Jacomb PA, Christensen H, Rodgers B, Pollitt P. ‘Mental health literacy’: A survey of the public's ability to recognise mental disorders and their beliefs about the effectiveness of treatment. Medical Journal of Australia 1997a; 166: 182–186
  • Jorm AF, Korten AE, Jacomb PA, Rodgers B, Pollitt P, Christensen H, et al. Helpfulness of interventions for mental disorders: Beliefs of health professionals compared with the general public. British Journal of Psychiatry 1997b; 171: 233–237
  • Kavanagh DJ, Greenaway L, Jenner L, Saunders JB, White A, Sorban J, et al. Contrasting views and experiences of health professionals on the management of comorbid substance misuse and mental disorders. Australian and New Zealand Journal of Psychiatry 2000; 34: 279–289
  • Lewin SA, Skea ZC, Entwistle V, Zwarenstein NM, Dick J. Interventions for providers to promote a patient-centred approach in clinical consultations. Cochrane Database of Systematic Reviews 2001 2001; 4
  • Manns L. Comorbidity: Why does it matter? (A consumer perspective). Comorbid mental disorders and substance use disorders: Epidemiology, prevention and treatment, M Teesson, H Proudfoot. Australian Government Department of Health and Ageing, CanberraAustralia 2003; 143–146
  • Mead N, Bower P. Patient-centredness: A conceptual framework and review of the empirical literature. Social Science & Medicine 2000; 51: 1087–1110
  • Merikangas KR, Mehta RL, Molnar BE, Walters EE, Swendsen JD, Aguilar-Gaziola S, et al. Comorbidity of substance use disorders with mood and anxiety disorders: Results of the International Consortium in Psychiatric Epidemiology. Addictive Behaviors 1998; 23: 893–907
  • National Treatment Agency for Substance Misuse. User and carer involvement: Guidance notes to adult treatment plans 2007/08. National Treatment Agency for Substance Misuse, London 2006
  • Health. NSW. The management of people with a co-existing substance use and mental health disorder. NSW Health Department, SydneyAustralia 2000
  • Nutbeam D. Health literacy as a public health goal: A challenge for contemporary health education and communication strategies into the 21st century. Health Promotion International 2000; 15: 259–267
  • Potter J, Wetherell M. Discourse and social psychology: Beyond attitudes and behaviour. Sage, London 1987
  • Pound P, Britten N, Morgan M, Yardley L, Pope C, Daker-White G, et al. Resisting medicines: A synthesis of qualitative studies of medicine taking. Social Science & Medicine 2005; 61: 133–155
  • Proudfoot H, Teesson M, Brewin E, Gournay K. Comorbidity and delivery of services. Comorbid mental disorders and substance use disorders: Epidemiology, prevention and treatment, M Teesson, H Proudfoot. Australian Government Department of Health and Ageing, CanberraAustralia 2003; 121–142
  • Rogers A, Pilgrim D. The contribution of lay knowledge to the understanding and promotion of mental health. Journal of Mental Health 1997; 6: 23–36
  • Ross J, Teesson M, Darke S, Lynskey M, Ali R, Ritter A, et al. The characteristics of heroin users entering treatment: Findings from the Australian Treatment Outcome Study (ATOS). Drug and Alcohol Review 2005; 24: 411–418
  • Siegfried N. A review of comorbidity: Major mental illness and problematic substance use. Australian and New Zealand Journal of Psychiatry 1998; 32: 707–717
  • Siegfried N, Ferguson J, Cleary M, Walter G, Rey JM. Experience, knowledge and attitudes of mental health staff regarding patients’ problematic drug and alcohol use. Australian and New Zealand Journal of Psychiatry 1999; 33: 267–273
  • Siggins Miller Consultants. Current practice in the management of clients with comorbid mental health and substance use disorders in tertiary care settings. Commonwealth Department of Health and Ageing, CanberraAustralia 2003
  • Teesson M, Burns L. National comorbidity project. Commonwealth Department of Health and Aged Care, CanberraAustralia 2001
  • Teesson M, Hall W, Lynskey M, Degenhardt L. Alcohol- and drug-use disorders in Australia: Implications of the National Survey of Mental Health and Wellbeing. Australian and New Zealand Journal of Psychiatry 2000; 34: 206–213
  • Teesson M, Havard A, Fairbairn S, Ross J, Lynskey M, Darke S. Depression among entrants to treatment for heroin dependence in the Australian Treatment Outcome Study (ATOS): Prevalence, correlates and treatment seeking. Drug & Alcohol Dependence 2005; 78: 309–15
  • Teesson M, Proudfoot H. Comorbid mental disorders and substance use disorders: epidemiology, prevention and treatment. Australian Government Department of Health and Ageing, CanberraAustralia 2003
  • Thompson A, Hunt C, Issakidis C. Why wait? Reasons for delay and prompts to seek help for mental-health problems in an Australian clinical sample. Social Psychiatry & Psychiatric Epidemiology 2004; 39: 810–817
  • Treloar C, Abelson J, Cao W, Brener L, Kippax S, Schultz L, et al. Barriers and incentives to treatment for illicit drug users. Australian Government Department of Health and Ageing, CanberraAustralia 2004
  • Treloar C, Holt M. Deficit models and divergent philosophies: Service providers’ perspectives on barriers and incentives to drug treatment. Drugs: Education, Prevention and Policy 2006; 13: 367–382
  • Wiessing L, Denis B, Guttormsson U, Haas S, Hamouda S, Hariga F, Hoch E, Imbert E, De Maere W, Nociar A, Origer A, Partanen A, Rajniaková T, Rhodes T, Rodés A, S˘ejda J, Terzidou M, Kraus L, Kümmler P, Burkhart G, Hartnoil R. Estimating coverage of harm reduction measures for injecting drug users in Europe. Paper prepared for the Third Annual Meeting of the Global Research Network on HIV Prevention in Drug-Using Populations. EMCDDA, Lisbon 2001, (Avilable at: http://www.emcdda.europa.eu/index.cfm?fuseaction=public.AttachmentDownload&NodeId=1527&SlanguageISO=EN.Date last accessed 23 June 2008)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.